Emerging Treatments for Residual Symptoms of Major Depressive Disorder: Focus on Insomnia

Emerging Treatments for Residual Symptoms of Major Depressive Disorder: Focus on Insomnia

Join us for a symposium on major depressive disorder (MDD) designed to encourage the exchange of ideas between leaders in the field and attendees. Topics discussed will include adjunctive treatments for MDD in the pipeline; current clinical trials investigating agents with novel mechanisms of action for the treatment of residual symptoms of MDD; how these agents may affect the future treatment of MDD; the effect on quality of life in these individuals; and how these novel, investigational agents will likely fit into the current treatment paradigm for MDD.

Moderator/Course Director
Leslie L. Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Paul P. Doghramji, MD
Family Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, Pennsylvania

Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Earn free 0.50 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event.

Click the link to view the Accreditation and Disclosure details before participating: https://www.medscape.org/s/viewarticle/emerging-treatments-residual-symptoms-major-depressive-2025a1000e6k

Supported by an independent educational grant from Janssen Pharmaceuticals.